EEG-Triggered rTMS and Group Therapy for Adolescents With Depression and Self-Harm
Real-time EEG-Triggered Transcranial Magnetic Stimulation Combined With Group Therapy for Adolescents With Depression and Self-Harm Behavior: A Randomized Controlled Trial
1 other identifier
interventional
160
1 country
1
Brief Summary
This randomized controlled trial aims to evaluate the efficacy of real-time EEG-triggered repetitive transcranial magnetic stimulation (rTMS) combined with group therapy versus rTMS alone in adolescents (aged 12-18 years) diagnosed with depression and exhibiting recent self-harm behavior. The primary outcome is the change in depression severity at 4 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Jun 2024
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFirst Submitted
Initial submission to the registry
June 24, 2025
CompletedFirst Posted
Study publicly available on registry
July 2, 2025
CompletedJuly 2, 2025
June 1, 2024
7 months
June 24, 2025
June 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Hamilton Depression Rating Scale (HAMD-24) scores
The HAMD-24 is a clinician-rated scale to assess the severity of depressive symptoms. Higher scores indicate greater severity of depression. Change is calculated as score at week 4 minus score at baseline.
Baseline and Week 4 (post-intervention)
Secondary Outcomes (8)
Change in Hamilton Anxiety Rating Scale (HAMA-14) scores
Baseline and Week 4
Change in Suicide Probability Scale (SPS) scores
Baseline and Week 4
Change in Modified Self-Harm Inventory (MSHI) scores
Baseline and Week 4
Change in Event-Related Potential (ERP) P300 Latency
Baseline and Week 4
Change in Event-Related Potential (ERP) P300 Amplitude
Baseline and Week 4
- +3 more secondary outcomes
Study Arms (2)
Real-time EEG-triggered rTMS Alone
ACTIVE COMPARATORParticipants received 20 sessions of real-time EEG-triggered rTMS over 4 weeks (5 sessions/week).
Real-time EEG-triggered rTMS + Group Therapy
EXPERIMENTALParticipants received identical rTMS (as the control group) plus semi-closed group therapy sessions.
Interventions
Stimulation target: left dorsolateral prefrontal cortex (DLPFC; F3 electrode position, 10-20 EEG system); Frequency: 10 Hz; Intensity: 110% of resting motor threshold (RMT); Pulse number: 2000 pulses/session (20 trains of 100 pulses, 30-second inter-train interval); EEG triggering: Stimulation pulses synchronized to the peak of the participant's ongoing θ-wave (4-7 Hz) activity. Duration: 20 sessions over 4 weeks.
Semi-closed group therapy; 10 participants/group, 2 sessions/week, 90 minutes/session for 4 weeks (total 8 sessions). Content included: Sessions 1-2: Emotional recognition and expression training; Sessions 3-4: Cognitive restructuring; Sessions 5-6: Impulse control training; Sessions 7-8: Self-esteem building and future planning.
Eligibility Criteria
You may qualify if:
- Age 12-18 years;
- Diagnosis of major depressive disorder (MDD) according to the International Classification of Diseases, 10th Revision (ICD-10 F32);
- Documented self-harm behavior within 2 weeks prior to enrollment (defined as deliberate self-injury without suicidal intent, e.g., cutting, burning);
- Hamilton Depression Rating Scale (HAMD-24) score ≥17 at baseline;
- Ability to complete self-report measures and participate in group therapy.
You may not qualify if:
- Comorbid psychotic disorders (e.g., schizophrenia), bipolar disorder, or autism spectrum disorder;
- History of neurological conditions (e.g., epilepsy, traumatic brain injury);
- Current use of electroconvulsive therapy;
- Refusal to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
Related Publications (1)
Liu H, Liu S, Yu M, Xin B, Liu Y. Real-time EEG-triggered transcranial magnetic stimulation combined with group therapy for adolescents with depression and self-harm behavior: A randomized controlled trial. J Affect Disord. 2026 Jan 1;392:120144. doi: 10.1016/j.jad.2025.120144. Epub 2025 Aug 26.
PMID: 40876639DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 24, 2025
First Posted
July 2, 2025
Study Start
June 1, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
July 2, 2025
Record last verified: 2024-06